| |
| |
|
| Insider
Information: |
Mahboob Vaseem |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
125,799 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,815 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
125,799 |
|
|
| Total
Value |
$2,815 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endologix Inc |
ELGX |
Chief Financial Officer |
2020-03-24 |
111,716 |
2015-10-15 |
0 |
Premium* |
|
|
Insys Therapeutics, Inc. |
INSY |
Director |
2019-03-04 |
14,083 |
2019-03-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2020-03-24 |
4 |
D |
$0.94 |
$3,408 |
D/D |
(3,625) |
111,716 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2020-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
47,010 |
115,341 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-12-30 |
4 |
D |
$1.68 |
$5,700 |
D/D |
(3,393) |
115,341 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
47,010 |
118,734 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-12-13 |
4 |
D |
$2.55 |
$7,599 |
D/D |
(2,986) |
118,733 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
47,010 |
121,719 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
32,400 |
121,720 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
89,320 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2019-04-03 |
4 |
B |
$6.61 |
$99,996 |
D/D |
15,128 |
76,820 |
2.74 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,083 |
14,083 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2018-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
470,115 |
616,927 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2018-08-16 |
4 |
B |
$2.43 |
$72,900 |
D/D |
30,000 |
146,812 |
2.74 |
- |
|
| ELGX |
Endologix Inc |
VP, Quality |
• – – |
2018-03-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,000) |
116,812 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2018-02-07 |
4 |
D |
$4.05 |
$18,760 |
D/D |
(4,632) |
144,812 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2018-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
33,201 |
149,444 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
149,444 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
121,186 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-04-06 |
4 |
D |
$6.75 |
$34,992 |
D/D |
(5,184) |
93,186 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
55,310 |
98,370 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
55,310 |
103,592 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-02-27 |
4 |
D |
$6.41 |
$33,473 |
D/D |
(5,222) |
98,370 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-02-07 |
4 |
D |
$6.94 |
$34,138 |
D/D |
(4,919) |
103,592 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
33,201 |
108,511 |
0 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2016-12-13 |
4 |
B |
$6.25 |
$125,000 |
D/D |
20,000 |
108,511 |
2.74 |
- |
|
| ELGX |
Endologix Inc |
Chief Financial Officer |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
33,201 |
88,511 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
